48,830
edits
Difference between revisions of "Pulmonary embolism"
Jump to navigation
Jump to search
m
→Risks factors (VTE): w
m (+marrow) |
m (→Risks factors (VTE): w) |
||
| Line 26: | Line 26: | ||
*Hypercoagulable states (memory device ''CALM SHAPES''):<ref name=pmid11700155>{{cite journal |author=Thomas RH |title=Hypercoagulability syndromes |journal=Arch. Intern. Med. |volume=161 |issue=20 |pages=2433–9 |year=2001 |month=November |pmid=11700155 |doi= |url=http://archinte.highwire.org/cgi/content/full/161/20/2433}}</ref> | *Hypercoagulable states (memory device ''CALM SHAPES''):<ref name=pmid11700155>{{cite journal |author=Thomas RH |title=Hypercoagulability syndromes |journal=Arch. Intern. Med. |volume=161 |issue=20 |pages=2433–9 |year=2001 |month=November |pmid=11700155 |doi= |url=http://archinte.highwire.org/cgi/content/full/161/20/2433}}</ref> | ||
**Protein C deficiency. | **Protein C deficiency. | ||
**Antiphospholipid antibody syndrome (APLA). | **[[Antiphospholipid antibody syndrome]] (APLA). | ||
**Leiden factor V deficiency. | **Leiden factor V deficiency. | ||
**Malignancy. | **Malignancy. | ||